India's Pharmaceutical Exports

Country Profile

Bahrain

Bahrain is an emerging destination for Indian pharmaceutical exports — $9.19M in FY 2025–26, with 2.5× growth over the past decade. Medicines accounts for 84% of shipments, with vaccines contributing $14K. The compound annual growth rate since FY2016 stands at 9.6%.

🇧🇭 $9.19M · 2.5× growth since FY2016 · 9.6% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$9.19M
Exports FY2025–26 DGCIS
2.5×
Growth FY2016→2026
9.6%
CAGR FY2016→2026
84%
Medicines Share
5
Product Categories Supplied
Bahrain is an emerging destination for Indian pharmaceutical exports — $9.19M in FY 2025–26, with 2.5× growth over the past decade. Medicines accounts for 84% of shipments, with vaccines contributing $14K. The compound annual growth rate since FY2016 stands at 9.6%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $7.76M (84.4%) Traditional & Herbal $591K (6.4%) Surgical & Hospital Supplies $464K (5.1%) Medicine Ingredients $362K (3.9%) Vaccines $14K (0.2%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Bahrain in the RBI overseas direct investment dataset (2011–2026).